Mirae Asset Global Investments
AVNS icon

Mirae Asset Global Investments’s Avanos Medical AVNS Stock Holding History

Mirae Asset Global Investments’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,339
Closed -$587K – 1614
2024
Q1 		$587K Sell
20,339
-329
-2% -$6.36K ﹤0.01% 1827
2023
Q4 		$464K Hold
20,668
– – ﹤0.01% 2005
2023
Q3 		$418K Buy
20,668
+329
+2% +$7.46K ﹤0.01% 1974
2023
Q2 		$520K Hold
20,339
– – ﹤0.01% 1931
2023
Q1 		$605K Hold
20,339
– – ﹤0.01% 1834
2022
Q4 		$550K Hold
20,339
– – ﹤0.01% 1833
2022
Q3 		$443K Buy
20,339
+5,950
+41% +$155K ﹤0.01% 1944
2022
Q2 		$393K Buy
+14,389
New +$413K ﹤0.01% 1860

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Mirae Asset Global Investments's AVNS Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 20,339 shares — an estimated $587K sold.

Mirae Asset Global Investments first reported a position in AVNS in Q2 2022 and held it in 8 quarters. The position peaked at $605K in Q1 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 20,339 Avanos Medical shares in Q2 2024, an estimated $587K.
  • Mirae Asset Global Investments first reported a position in Avanos Medical in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Avanos Medical position peaked at $605K in Q1 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.